Implementation of an Evidence Based Post-Traumatic Stress Disorder (PTSD) Treatment in Public Sector Settings
Primary Purpose
Post-Traumatic Stress Disorder
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
STAIR/NT treatment
Treatment as Usual (TAU)
Sponsored by
About this trial
This is an interventional treatment trial for Post-Traumatic Stress Disorder focused on measuring Stress Disorders, Post-Traumatic, PTSD, Adult Survivors of Child Abuse, Women, Interpersonal violence, psychological trauma
Eligibility Criteria
Inclusion Criteria:
- A primary diagnosis of PTSD according to DSM-IV criteria with a CAPS score no lower than 40 (cf Weathers, Keane, & Davidson, 2001)
- PTSD symptoms that are a result of interpersonal violence
- at least one clear trauma memory
- Current age between 18 and 65
- If obtaining other (medication or psychosocial) treatment, must have completed at least a 3 month course of the treatment
Exclusion Criteria:
- Substance dependence and severe substance abuse disorders, current psychotic symptoms, unmedicated mania or bipolar disorder
- prominent current suicidal or homicidal ideation (a plan or intent versus a wish) or a suicide attempt within the past three months
- self-injurious behaviors in the last three months requiring medical attention
- Cognitive impairment indicated by chart diagnoses or observable cognitive difficulties
- Current involvement in a violent relationship defined as more than casual contact (e.g. dating or living with an abusive partner)
Sites / Locations
- University of Connecticut Health Center
- Georgetown University School of Medicine
- Grady Health System
- Cambridge Health Alliance
- New York University- Bellevue
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Other
Arm Label
STAIR/NT
Treatment as Usual (TAU)
Arm Description
Patients will receive STAIR/NT treatment
Patients will receive Treatment as Usual (TAU)
Outcomes
Primary Outcome Measures
Clinician Assessed PTSD Symptom Severity
Clinician Adminstered PTSD Scale for DSM-5 (CAPS-5) includes 20 items rated on a 5 point scale from 0 to 4. Possible total scores range from 0 to 80, with higher scores indicating more severe PTSD.
PTSD Diagnosis
Clinician Adminstered PTSD Scale for DSM-5 (CAPS-5) assess the presence of PTSD diagnosis following the requirements indicated by DSM-5. These include the presence of 5 symtpom clusters that include re-experiencing symptoms, avoidance symptoms, alterations in mood and cognitions and hyperarousal.
Secondary Outcome Measures
Emotion Regulation Problems
The DERS is a 36 item self-report measure where items are scored from 0 to 4 indicating how frequently the problem occurs. Possible total scores can range from 0 to 144 with higher scores indicating more frequent problems.
Interpersonal problems
The Inventory of Interpersonal Problems-32 (IIP-32) is a 32 item measure where items are scored from 0 to 4. Possible total scores range from 0 to 128 with higher scores indicating more severe problems.
Psychosocial Functioning
SF-3 includes 3 items from the SF-36 which assess the impact of emotional problems on daily functioning
Full Information
NCT ID
NCT01488539
First Posted
December 2, 2011
Last Updated
August 15, 2023
Sponsor
Palo Alto Veterans Institute for Research
Collaborators
New York University, Grady Health System, Nathan Kline Institute for Psychiatric Research, Georgetown University, Harvard Medical School (HMS and HSDM), UConn Health, VA New York Harbor Healthcare System, National Institute of Mental Health (NIMH)
1. Study Identification
Unique Protocol Identification Number
NCT01488539
Brief Title
Implementation of an Evidence Based Post-Traumatic Stress Disorder (PTSD) Treatment in Public Sector Settings
Official Title
Implementation of an Evidence Based PTSD Treatment in Public Sector Settings
Study Type
Interventional
2. Study Status
Record Verification Date
August 2023
Overall Recruitment Status
Completed
Study Start Date
January 1, 2012 (Actual)
Primary Completion Date
April 1, 2016 (Actual)
Study Completion Date
April 1, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Palo Alto Veterans Institute for Research
Collaborators
New York University, Grady Health System, Nathan Kline Institute for Psychiatric Research, Georgetown University, Harvard Medical School (HMS and HSDM), UConn Health, VA New York Harbor Healthcare System, National Institute of Mental Health (NIMH)
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Researchers hope to learn whether a flexibly applied cognitive behavioral treatment for Post-Traumatic Stress Disorder (PTSD) is more effective than the psychotherapy usually provided in the clinic (called Treatment as Usual or TAU). Primary Hypothesis: STAIR/NT will be superior to TAU in improving PTSD symptoms at 28, 36 and 48 weeks post-randomization
Detailed Description
PTSD among women is a particularly pernicious and chronic disorder associated with significant psychiatric comorbidity, high rates of suicidality, substance abuse, self-injury and multiple traumatization including repeated sexual assault and domestic violence. Public-sector mental health services are the disproportionate recipient of traumatized women with between 62% to 98% of treatment seeking women reporting a history of trauma and of those, up to 40% carry a diagnosis of PTSD with various comorbidities. Over 40 single-site randomized trials of cognitive-behavioral therapy for PTSD have been conducted. However, to date, there are only two large-sample randomized clinical trials which have evaluated the effectiveness of such treatments in the community and both of them concerned military populations. This application proposes to evaluate the effectiveness of an evidence-based PTSD treatment in the context of a collaborative partnership of four public mental health clinics serving diverse populations. The intervention is a two module, sequential treatment (STAIR/NT) in which the first module emphasizes present-focused skills training in affective and interpersonal regulation (STAIR) for day-to-day life difficulties and the second module incorporates past-focused work on the processing of the trauma, using narrative therapy (NT). This cognitive behavioral treatment was specifically designed to treat high risk, multiply traumatized women with chronic PTSD and has been demonstrated to provide significant and clinically substantial relief from PTSD as well as improvement in emotion management and interpersonal functioning.
The investigators will assess the effectiveness of STAIR/NT compared to Treatment as Usual (TAU) in the context of every day clinical care. The study is a randomized, controlled repeated measures intent-to-treat design to assess STAIR/NT as compared to TAU at post-treatment and three and six-month follow-up. Four sites (Western Ontario, Boston, New York and Atlanta), each situated within a large public sector mental health network, will enroll 88 treatment-seeking women with PTSD related to interpersonal violence yielding a total of 352 study participants. The primary outcome will be PTSD symptom severity. Secondary outcomes will be negative mood regulation self-efficacy, interpersonal problems and general level of psychiatric impairment (GAF scores). Exploratory aims include the examination of the relationship between variations in treatment implementation and treatment outcome as well as the influence of patient characteristics and other contextual (therapist and organization) variables likely to impact implementation. The investigators will also introduce web-based technology as a resource intended to strengthen clinical networks and maintain use of study materials after the trial has ended.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Post-Traumatic Stress Disorder
Keywords
Stress Disorders, Post-Traumatic, PTSD, Adult Survivors of Child Abuse, Women, Interpersonal violence, psychological trauma
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
210 (Actual)
8. Arms, Groups, and Interventions
Arm Title
STAIR/NT
Arm Type
Experimental
Arm Description
Patients will receive STAIR/NT treatment
Arm Title
Treatment as Usual (TAU)
Arm Type
Other
Arm Description
Patients will receive Treatment as Usual (TAU)
Intervention Type
Behavioral
Intervention Name(s)
STAIR/NT treatment
Intervention Description
STAIR/NT is a two module, sequential treatment in which the first module emphasizes present-focused skills training in affective an interpersonal regulation (STAIR) for day-to-day life difficulties and the second module incorporates past-focused work on the processing of the trauma, using narrative therapy (NT). STAIR/NT is a cognitive behavioral treatment that can be flexibly applied allowing treatment tailored to the needs of the individual patient; may be as brief as 16 sessions and as long as 24.
Intervention Type
Behavioral
Intervention Name(s)
Treatment as Usual (TAU)
Intervention Description
The Treatment as Usual intervention content varies from site to site and involve some combination of psychotherapy and pharmacotherapy. Treatment duration varies across sites and ranges from 30 to 45 sessions.
Primary Outcome Measure Information:
Title
Clinician Assessed PTSD Symptom Severity
Description
Clinician Adminstered PTSD Scale for DSM-5 (CAPS-5) includes 20 items rated on a 5 point scale from 0 to 4. Possible total scores range from 0 to 80, with higher scores indicating more severe PTSD.
Time Frame
Baseline, 28, 36, 48 weeks
Title
PTSD Diagnosis
Description
Clinician Adminstered PTSD Scale for DSM-5 (CAPS-5) assess the presence of PTSD diagnosis following the requirements indicated by DSM-5. These include the presence of 5 symtpom clusters that include re-experiencing symptoms, avoidance symptoms, alterations in mood and cognitions and hyperarousal.
Time Frame
Baseline, 28, 36, 48 weeks
Secondary Outcome Measure Information:
Title
Emotion Regulation Problems
Description
The DERS is a 36 item self-report measure where items are scored from 0 to 4 indicating how frequently the problem occurs. Possible total scores can range from 0 to 144 with higher scores indicating more frequent problems.
Time Frame
Baseline, 12, 28, 36, 48 weeks
Title
Interpersonal problems
Description
The Inventory of Interpersonal Problems-32 (IIP-32) is a 32 item measure where items are scored from 0 to 4. Possible total scores range from 0 to 128 with higher scores indicating more severe problems.
Time Frame
Baseline, 12, 28, 36, 48 weeks
Title
Psychosocial Functioning
Description
SF-3 includes 3 items from the SF-36 which assess the impact of emotional problems on daily functioning
Time Frame
Baseline, 28, 36, 48 weeks
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
A primary diagnosis of PTSD according to DSM-IV criteria with a CAPS score no lower than 40 (cf Weathers, Keane, & Davidson, 2001)
PTSD symptoms that are a result of interpersonal violence
at least one clear trauma memory
Current age between 18 and 65
If obtaining other (medication or psychosocial) treatment, must have completed at least a 3 month course of the treatment
Exclusion Criteria:
Substance dependence and severe substance abuse disorders, current psychotic symptoms, unmedicated mania or bipolar disorder
prominent current suicidal or homicidal ideation (a plan or intent versus a wish) or a suicide attempt within the past three months
self-injurious behaviors in the last three months requiring medical attention
Cognitive impairment indicated by chart diagnoses or observable cognitive difficulties
Current involvement in a violent relationship defined as more than casual contact (e.g. dating or living with an abusive partner)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marylene Cloitre, PhD
Organizational Affiliation
VA Palo Alto Health Care System
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Connecticut Health Center
City
Farmington
State/Province
Connecticut
ZIP/Postal Code
06030
Country
United States
Facility Name
Georgetown University School of Medicine
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20057
Country
United States
Facility Name
Grady Health System
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30303
Country
United States
Facility Name
Cambridge Health Alliance
City
Cambridge
State/Province
Massachusetts
ZIP/Postal Code
02139
Country
United States
Facility Name
New York University- Bellevue
City
New York
State/Province
New York
ZIP/Postal Code
10016
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
24886235
Citation
Cloitre M, Henn-Haase C, Herman JL, Jackson C, Kaslow N, Klein C, Mendelsohn M, Petkova E. A multi-site single-blind clinical study to compare the effects of STAIR Narrative Therapy to treatment as usual among women with PTSD in public sector mental health settings: study protocol for a randomized controlled trial. Trials. 2014 May 29;15:197. doi: 10.1186/1745-6215-15-197.
Results Reference
background
Learn more about this trial
Implementation of an Evidence Based Post-Traumatic Stress Disorder (PTSD) Treatment in Public Sector Settings
We'll reach out to this number within 24 hrs